Prohibits certain steering and marketing practices involving dispensing of prescription drugs and drug samples.

S 2891 prohibits drug manufacturers, pharmacies, wholesalers, and healthcare providers from using devices, kiosks, or systems to steer patients to specific pharmacies or restrict their pharmacy choice when dispensing prescription drugs or samples. It requires explicit patient consent before transmitting personal health information to a particular pharmacy, with full disclosure of the patient’s right to choose their pharmacy or decline sharing information. Violations carry significant penalties: $100,000+ for companies per violation and $250+ for healthcare providers. The bill directly affects patients (by protecting their pharmacy choice), healthcare practitioners, and pharmaceutical entities. It aims to prevent restrictive marketing practices without altering existing authority for prescribing drugs.